BRUSSELS, June 3 (Reuters) - U.S. disease diagnosis firm Gen-Probe Inc launched a 215 million euro ($335.4 million) counterbid for Belgian peer Innogenetics NV on Tuesday, trumping an offer from local ...
Hologic ($HOLX) will become a major player in molecular diagnostics focused on sexually transmitted diseases and boost its women's health expertise with the company's ...
Enterome developed GeneMark-HM software in collaboration with Gene Probe Inc. PARIS, June 16, 2021 /PRNewswire/ -- ENTEROME SA, a clinical stage biopharmaceutical company developing novel drugs based ...
Gen-Probe Inc. (NSDQ:GPRO) bought Waukesha, Wis.-based GTI Diagnostics in a self-funded $53 million cash deal. The acquisition allows the San Diego-based company to expand its transplant diagnostics ...
Medical device maker Hologic Inc. has agreed to buy diagnostic test maker Gen-Probe Inc. for about $3.72 billion, expanding its portfolio in an area of medicine expected to see big growth. Gen-Probe ...
LOS ANGELES, July 31 (Reuters) - Gen-Probe Inc Inc said on Thursday its second-quarter net income fell 8 percent as record sales of clinical diagnostics products and blood screening tests failed to ...
NEW YORK (MarketWatch) -- Gen-Probe Inc. Thursday said it's reached a settlement of its patent litigations and contract arbitrations with Bayer Healthcare LLC, a unit of Bayer Group . The deal calls ...
Firm has molecular tests for respiratory infectious diseases. Gen-Probe plans on acquiring Prodesse for approximately $60 million in cash. Achievement of certain financial and regulatory milestones in ...
Diagnostic products maker Gen-Probe Inc. (:GPRO) has secured the approval of the U.S. Food and Drug Administration ("FDA") for its PROGENSA PCA3 assay, a novel molecular test designed to aid the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback